Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg-1 rifampicin.

2021
https://researcherprofiles.org/profile/171995613
33542056
Te Brake LHM, de Jager V, Narunsky K, Vanker N, Svensson EM, Phillips PPJ, Gillespie SH, Heinrich N, Hoelscher M, Dawson R, Diacon AH, Aarnoutse RE, Boeree MJ